SOLUPRED

Solupred Adverse Events Reported to the FDA Over Time

How are Solupred adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Solupred, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Solupred is flagged as the suspect drug causing the adverse event.

Most Common Solupred Adverse Events Reported to the FDA

What are the most common Solupred adverse events reported to the FDA?

Diarrhoea	27 (1.48%)
Anaemia	26 (1.43%)
Toxic Skin Eruption	23 (1.26%)
Cytolytic Hepatitis	22 (1.21%)
Pyrexia	21 (1.15%)
Neutropenia	20 (1.1%)
Vomiting	18 (.99%)
Abdominal Pain	17 (.93%)
Drug Interaction	16 (.88%)
Inflammation	16 (.88%)
Purpura	15 (.82%)
	Show More
Renal Failure Acute	15 (.82%)
Tremor	15 (.82%)
Erythema	14 (.77%)
International Normalised Ratio Incr...	14 (.77%)
Lung Disorder	14 (.77%)
Malaise	14 (.77%)
Thrombocytopenia	14 (.77%)
Memory Impairment	13 (.71%)
Condition Aggravated	11 (.6%)
Dyspnoea	11 (.6%)
Nausea	11 (.6%)
Oedema Peripheral	11 (.6%)
Pruritus	11 (.6%)
Rash	11 (.6%)
Rash Erythematous	11 (.6%)
Alanine Aminotransferase Increased	10 (.55%)
Arthralgia	10 (.55%)
Aspartate Aminotransferase Increase...	10 (.55%)
Cholestasis	10 (.55%)
Pancreatitis Acute	10 (.55%)
Asthenia	9 (.49%)
Haematoma	9 (.49%)
Osteonecrosis	9 (.49%)
Rash Macular	9 (.49%)
Sepsis	9 (.49%)
Transplant Rejection	9 (.49%)
Arthritis	8 (.44%)
Blood Creatinine Increased	8 (.44%)
Confusional State	8 (.44%)
Cytomegalovirus Infection	8 (.44%)
Disorientation	8 (.44%)
Drug Ineffective	8 (.44%)
Rash Maculo-papular	8 (.44%)
Skin Lesion	8 (.44%)
Agranulocytosis	7 (.38%)
Cardio-respiratory Arrest	7 (.38%)
Convulsion	7 (.38%)
Cough	7 (.38%)
Deep Vein Thrombosis	7 (.38%)
Dysarthria	7 (.38%)
Fatigue	7 (.38%)
Hallucination, Auditory	7 (.38%)
Hepatitis	7 (.38%)
Hepatitis Cholestatic	7 (.38%)
Hypokalaemia	7 (.38%)
Jaundice	7 (.38%)
Lymphopenia	7 (.38%)
Nephrotic Syndrome	7 (.38%)
Nervous System Disorder	7 (.38%)
Pancreatitis	7 (.38%)
Somnolence	7 (.38%)
Stevens-johnson Syndrome	7 (.38%)
Subdural Haematoma	7 (.38%)
Acute Generalised Exanthematous Pus...	6 (.33%)
Cerebellar Syndrome	6 (.33%)
Cerebral Haemorrhage	6 (.33%)
Chromaturia	6 (.33%)
Coma	6 (.33%)
Dermatitis Bullous	6 (.33%)
Drug Exposure During Pregnancy	6 (.33%)
Eosinophilia	6 (.33%)
Fall	6 (.33%)
Gamma-glutamyltransferase Increased	6 (.33%)
Gastrointestinal Disorder	6 (.33%)
Grand Mal Convulsion	6 (.33%)
Haemorrhage	6 (.33%)
Hyperglycaemia	6 (.33%)
Hyperthermia	6 (.33%)
Hyperuricaemia	6 (.33%)
Insomnia	6 (.33%)
Leukopenia	6 (.33%)
Lipase Increased	6 (.33%)
Malignant Neoplasm Progression	6 (.33%)
Overdose	6 (.33%)
Platelet Count Decreased	6 (.33%)
Renal Failure	6 (.33%)
Renal Vein Thrombosis	6 (.33%)
Skin Exfoliation	6 (.33%)
Vasculitis	6 (.33%)
Abdominal Pain Upper	5 (.27%)
Acute Respiratory Failure	5 (.27%)
Colitis Ischaemic	5 (.27%)
Diabetes Mellitus	5 (.27%)
Diabetes Mellitus Inadequate Contro...	5 (.27%)
Febrile Neutropenia	5 (.27%)
Gait Disturbance	5 (.27%)
Headache	5 (.27%)
Hypoalbuminaemia	5 (.27%)
Hypotension	5 (.27%)
Interstitial Lung Disease	5 (.27%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Solupred, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Solupred is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Solupred

What are the most common Solupred adverse events reported to the FDA?

Epidermal And Dermal Conditions	169 (9.28%)
Hepatic And Hepatobiliary	76 (4.17%)
Infections - Pathogen Unspecified	66 (3.62%)
Respiratory	66 (3.62%)
Gastrointestinal Signs	62 (3.4%)
Neurological	58 (3.18%)
White Blood Cell	56 (3.07%)
Anemias Nonhemolytic And Marrow Dep...	39 (2.14%)
Hematology Investigations	36 (1.98%)
Bacterial Infectious	34 (1.87%)
Gastrointestinal Motility And Defec...	32 (1.76%)
	Show More
Hepatobiliary	32 (1.76%)
Renal Disorders	31 (1.7%)
Body Temperature Conditions	27 (1.48%)
Injuries	27 (1.48%)
Movement Disorders	27 (1.48%)
Cardiac Arrhythmias	26 (1.43%)
Therapeutic And Nontherapeutic Effe...	26 (1.43%)
Joint	25 (1.37%)
Skin Vascular Abnormalities	24 (1.32%)
Seizures	21 (1.15%)
Deliria	20 (1.1%)
Exocrine Pancreas Conditions	19 (1.04%)
Lower Respiratory Tract Disorders	19 (1.04%)
Electrolyte And Fluid Balance Condi...	18 (.99%)
Glucose Metabolism Disorders	17 (.93%)
Muscle	17 (.93%)
Bone Disorders	16 (.88%)
Urinary Tract Signs	16 (.88%)
Vascular Hemorrhagic	15 (.82%)
Gastrointestinal Hemorrhages	14 (.77%)
Immune	14 (.77%)
Oral Soft Tissue Conditions	14 (.77%)
Physical Examination Topics	14 (.77%)
Platelet	14 (.77%)
Renal And Urinary Tract Investigati...	14 (.77%)
Cardiac And Vascular Investigations	13 (.71%)
Mental Impairment	13 (.71%)
Central Nervous System Vascular	12 (.66%)
Decreased And Nonspecific Blood Pre...	12 (.66%)
Fungal Infectious	12 (.66%)
Nephropathies	12 (.66%)
Viral Infectious	12 (.66%)
Disturbances In Thinking	11 (.6%)
Pulmonary Vascular	11 (.6%)
Vision	11 (.6%)
Medication Errors	10 (.55%)
Chemical Injury And Poisoning	9 (.49%)
Embolism And Thrombosis	9 (.49%)
Miscellaneous And Site Unspecified ...	9 (.49%)
Sleep Disorders	9 (.49%)
Tendon, Ligament And Cartilage	9 (.49%)
Vascular Inflammations	9 (.49%)
Bone And Joint Injuries	8 (.44%)
Hemolyses And Related Conditions	8 (.44%)
Purine And Pyrimidine Metabolism	8 (.44%)
Endocrine Investigations	7 (.38%)
Gastrointestinal Conditions	7 (.38%)
Gastrointestinal Inflammatory Condi...	7 (.38%)
Pigmentation	7 (.38%)
Pleural	7 (.38%)
Urolithiases	7 (.38%)
Angiedema And Urticaria	6 (.33%)
Cornification And Dystrophic Skin	6 (.33%)
Gastrointestinal	6 (.33%)
Ocular Infections, Irritations And ...	6 (.33%)
Peritoneal And Retroperitoneal Cond...	6 (.33%)
Protein And Amino Acid Metabolism	6 (.33%)
Skin Neoplasms Malignant And Unspec...	6 (.33%)
Water, Electrolyte And Mineral	6 (.33%)
Fatal Outcomes	5 (.27%)
Gastrointestinal Ulceration And Per...	5 (.27%)
Headaches	5 (.27%)
Immunodeficiency Syndromes	5 (.27%)
Mycobacterial Infectious	5 (.27%)
Neonatal And Perinatal Conditions	5 (.27%)
Ocular Neuromuscular	5 (.27%)
Spleen, Lymphatic And Reticulendoth...	5 (.27%)
Therapeutic Procedures And Supporti...	5 (.27%)
Tissue	5 (.27%)
Upper Respiratory Tract Disorders	5 (.27%)
Vascular Hypertensive	5 (.27%)
Abortions And Stillbirth	4 (.22%)
Acid-base	4 (.22%)
Allergic Conditions	4 (.22%)
Appetite And General Nutritional	4 (.22%)
Cardiac Disorder Signs	4 (.22%)
Coronary Artery	4 (.22%)
Encephalopathies	4 (.22%)
Enzyme	4 (.22%)
Inner Ear And Viiith Cranial Nerve	4 (.22%)
Musculoskeletal And Connective Tiss...	4 (.22%)
Neuromuscular	4 (.22%)
Procedural And Device Related Injur...	4 (.22%)
Skin And Subcutaneous Tissue	4 (.22%)
Adrenal Gland	3 (.16%)
Anxiety Disorders	3 (.16%)
Bone And Joint Therapeutic Procedur...	3 (.16%)
Bronchial Disorders	3 (.16%)
Dental And Gingival Conditions	3 (.16%)
Hematological And Lymphoid Tissue T...	3 (.16%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Solupred, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Solupred is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.